{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:57:48Z","timestamp":1793642268800,"version":"4.5.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,12,11]],"date-time":"2015-12-11T00:00:00Z","timestamp":1449792000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Autism Dev Disord"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s10803-015-2628-x","type":"journal-article","created":{"date-parts":[[2015,12,13]],"date-time":"2015-12-13T09:03:13Z","timestamp":1449997393000},"page":"1153-1163","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Lurasidone for the Treatment of Irritability Associated with Autistic Disorder"],"prefix":"10.1007","volume":"46","author":[{"given":"Antony","family":"Loebel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Brams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Mankoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Findling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,11]]},"reference":[{"key":"2628_CR1","first-page":"283","volume":"100","author":"MG Aman","year":"1995","unstructured":"Aman, M. G., Burrow, W. H., & Wolford, P. L. (1995). The Aberrant Behavior Checklist-Community: Factor validity and effect of subject variables for adults in group homes. American Journal of Mental Retardation, 100, 283\u2013292.","journal-title":"American Journal of Mental Retardation"},{"key":"2628_CR2","first-page":"570","volume":"91","author":"MG Aman","year":"1987","unstructured":"Aman, M. G., Richmond, G., Stewart, A. W., Bell, J. C., & Kissel, R. C. (1987). The aberrant behavior checklist: Factor structure and the effect of subject variables in American and New Zealand facilities. American Journal of Mental Deficiency, 91, 570\u2013578.","journal-title":"American Journal of Mental Deficiency"},{"key":"2628_CR3","first-page":"485","volume":"89","author":"MG Aman","year":"1985","unstructured":"Aman, M. G., Singh, N. N., Stewart, A. W., & Field, C. J. (1985). The aberrant behavior checklist: A behavior rating scale for the assessment of treatment effects. American Journal of Mental Deficiency, 89, 485\u2013491.","journal-title":"American Journal of Mental Deficiency"},{"key":"2628_CR4","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders, 4th Edition, text revision (DSM-IV-TR). Arlington: American Psychiatric Publishing.","DOI":"10.1176\/appi.books.9780890423349"},{"key":"2628_CR5","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-5","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-5. Washington, DC: American Psychiatric Association."},{"key":"2628_CR6","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","volume":"154","author":"TRE Barnes","year":"1989","unstructured":"Barnes, T. R. E. (1989). A rating scale for drug-induced akathisia. British Journal of Psychiatry, 154, 672\u2013676.","journal-title":"British Journal of Psychiatry"},{"key":"2628_CR7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/B:JADD.0000022606.97580.19","volume":"34","author":"EA Bradley","year":"2004","unstructured":"Bradley, E. A., Summers, J. A., Wood, H. L., & Bryson, S. E. (2004). Comparing rates of psychiatric and behavior disorders in adolescents and young adults with severe intellectual disability with and without autism. Journal of Autism and Developmental Disorders, 34, 151\u2013161.","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"2628_CR8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/106342669700500404","volume":"5","author":"AM Brannan","year":"1997","unstructured":"Brannan, A. M., Heflinger, C. A., & Bickman, L. (1997). The caregiver strain questionnaire: Measuring the impact on the family of living with a child with serious emotional disturbance. Journal of Emotional and Behavioral Disorders, 5, 212\u2013222.","journal-title":"Journal of Emotional and Behavioral Disorders"},{"key":"2628_CR9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0891-4222(01)00091-9","volume":"23","author":"EC Brown","year":"2002","unstructured":"Brown, E. C., Aman, M. G., & Havercamp, S. M. (2002). Factor analysis and norms for parent ratings on the Aberrant Behavior Checklist-Community for young people in special education. Research in Developmental Disabilities, 23, 45\u201360.","journal-title":"Research in Developmental Disabilities"},{"key":"2628_CR10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3233\/JPD-120165","volume":"3","author":"MB Callesen","year":"2013","unstructured":"Callesen, M. B., Scheel-Kr\u00fcger, J., Kringelbach, M. L., & M\u00f8ller, A. (2013). A systematic review of impulse control disorders in Parkinson\u2019s disease. Journal of Parkinsons Disease, 3, 105\u2013138.","journal-title":"Journal of Parkinsons Disease"},{"key":"2628_CR11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.chc.2013.08.002","volume":"23","author":"D Carroll","year":"2014","unstructured":"Carroll, D., Hallett, V., & McDougle, C. J. (2014). Examination of aggression and self-injury in children with autism spectrum disorders and serious behavioral problems. Child and Adolescent Psychiatric Clinics of North America, 23, 57\u201372.","journal-title":"Child and Adolescent Psychiatric Clinics of North America"},{"key":"2628_CR12","unstructured":"Centers for Disease Control and Prevention. (2000). Growth charts for the United States, 2000. Accessed on the web on May 6, 2015. http:\/\/www.cdc.gov\/growthcharts\/cdc_charts.htm"},{"key":"2628_CR13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/wps.20187","volume":"14","author":"CU Correll","year":"2015","unstructured":"Correll, C. U., Joffe, B. I., Rosen, L. M., Sullivan, T. B., & Joffe, R. T. (2015). Cardiovascular and cerebrovascular risk factors and events associated with second-generation antipsychotic compared to antidepressant use in a non-elderly adult sample: results from a claims-based inception cohort study. World Psychiatry, 14, 56\u201363.","journal-title":"World Psychiatry"},{"key":"2628_CR14","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2009.1549","volume":"302","author":"CU Correll","year":"2009","unstructured":"Correll, C. U., Manu, P., Olshanskiy, V., Napolitano, B., Kane, J. M., & Malhotra, A. K. (2009). Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA, 302, 1765\u20131773.","journal-title":"JAMA"},{"key":"2628_CR15","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1037\/a0031544","volume":"139","author":"AA Duke","year":"2013","unstructured":"Duke, A. A., B\u00e8gue, L., Bell, R., & Eisenlohr-Moul, T. (2013). Revisiting the serotonin-aggression relation in humans: a meta-analysis. Psychological Bulletin, 139, 1148\u20131172.","journal-title":"Psychological Bulletin"},{"key":"2628_CR16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2788.2005.00699.x","volume":"49","author":"AS Eisenhower","year":"2005","unstructured":"Eisenhower, A. S., Baker, B. L., & Blacher, J. (2005). Preschool children with intellectual disability: syndrome specificity, behaviour problems, and maternal well-being. Journal of Intellectual Disability Research, 49, 657\u2013671.","journal-title":"Journal of Intellectual Disability Research"},{"key":"2628_CR17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1517\/14740338.2015.979150","volume":"14","author":"B Galling","year":"2015","unstructured":"Galling, B., & Correll, C. U. (2015). Do antipsychotics increase diabetes risk in children and adolescents? Expert Opinion on Drug Safety, 14, 219\u2013241.","journal-title":"Expert Opinion on Drug Safety"},{"issue":"Suppl 1","key":"2628_CR18","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1055\/s-2006-931485","volume":"39","author":"G Gr\u00fcnder","year":"2006","unstructured":"Gr\u00fcnder, G., Kungel, M., Ebrecht, M., G\u00f6r\u00f6cs, T., & Modell, S. (2006). Aripiprazole: Pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia. Pharmacopsychiatry, 39(Suppl 1), S21\u2013S25.","journal-title":"Pharmacopsychiatry"},{"key":"2628_CR19","unstructured":"Guy, W. (1976). EDCEU assessment manual for psychopharmacology \u2014Revised (DHEW Publ No ADM 76-338). Rockville, MD, U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, pp. 534\u2013537."},{"key":"2628_CR20","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.rasd.2014.05.006","volume":"8","author":"AP Hill","year":"2014","unstructured":"Hill, A. P., Zuckerman, K. E., Hagen, A. D., Kriz, D. J., Duvall, S. W., van Santen, J., et al. (2014). Aggressive behavior problems in children with autism spectrum disorders: Prevalence and correlates in a large clinical sample. Research in Autism Spectrum Disorders, 8, 1121\u20131133.","journal-title":"Research in Autism Spectrum Disorders"},{"key":"2628_CR21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/jpet.110.167346","volume":"334","author":"T Ishibashi","year":"2010","unstructured":"Ishibashi, T., Horisawa, T., Tokuda, K., Ishiyama, T., Ogasa, M., Tagashira, R., et al. (2010). Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity. Journal of Pharmacology and Experimental Therapeutics, 334, 171\u2013181.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"2628_CR22","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s10803-013-1970-0","volume":"44","author":"AJ Kaat","year":"2014","unstructured":"Kaat, A. J., Lecavalier, L., & Aman, M. G. (2014). Validity of the aberrant behavior checklist in children with autism spectrum disorder. Journal of Autism and Developmental Disorders, 44, 1103\u20131116.","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"2628_CR23","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.psychres.2014.09.018","volume":"220","author":"A Kolevzon","year":"2014","unstructured":"Kolevzon, A., Lim, T., Schmeidler, J., Martello, T., Cook, E. H., Jr, & Silverman, J. M. (2014). Self-injury in autism spectrum disorder: An effect of serotonin transporter gene promoter variants. Psychiatry Research, 220, 987\u2013990.","journal-title":"Psychiatry Research"},{"key":"2628_CR24","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(13)61539-1","volume":"383","author":"MC Lai","year":"2014","unstructured":"Lai, M. C., Lombardo, M. V., & Baron-Cohen, S. (2014). Autism. Lancet, 383, 896\u2013910.","journal-title":"Lancet"},{"key":"2628_CR25","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s10803-006-0147-5","volume":"36","author":"L Lecavalier","year":"2006","unstructured":"Lecavalier, L. (2006). Behavioral and emotional problems in young people with pervasive developmental disorders: Relative prevalence, effects of subject characteristics, and empirical classification. Journal of Autism and Developmental Disorders, 36, 1101\u20131114.","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"2628_CR26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2788.2005.00732.x","volume":"50","author":"L Lecavalier","year":"2006","unstructured":"Lecavalier, L., Leone, S., & Wiltz, J. (2006). The impact of behaviour problems on caregiver stress in young people with autism spectrum disorders. Journal of Intellectual Disability Research, 50, 172\u2013183.","journal-title":"Journal of Intellectual Disability Research"},{"key":"2628_CR27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/1099-0798(200010)18:5<581::AID-BSL411>3.0.CO;2-L","volume":"18","author":"KP Lesch","year":"2000","unstructured":"Lesch, K. P., & Merschdorf, U. (2000). Impulsivity, aggression, and serotonin: a molecular psychobiological perspective. Behavioral Sciences & The Law, 18, 581\u2013604.","journal-title":"Behavioral Sciences & The Law"},{"key":"2628_CR28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.2013.13070984","volume":"171","author":"A Loebel","year":"2014","unstructured":"Loebel, A., Cucchiaro, J., Silva, R., Kroger, H., Hsu, J., Sarma, K., & Sachs, G. (2014a). Lurasidone monotherapy in the treatment of bipolar I depression: A randomized, double-blind, placebo-controlled study. American Journal of Psychiatry, 171, 160\u2013168.","journal-title":"American Journal of Psychiatry"},{"key":"2628_CR29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1176\/appi.ajp.2013.13070985","volume":"171","author":"A Loebel","year":"2014","unstructured":"Loebel, A., Cucchiaro, J., Silva, R., Kroger, H., Sarma, K., Xu, J., & Calabrese, J. R. (2014b). Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: A randomized, double-blind, placebo-controlled study. American Journal of Psychiatry, 171, 169\u2013177.","journal-title":"American Journal of Psychiatry"},{"key":"2628_CR30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/BF02172145","volume":"24","author":"C Lord","year":"1994","unstructured":"Lord, C., Rutter, M., & Le Couteur, A. (1994). Diagnostic interview-revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders, 24, 659\u2013685.","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"2628_CR31","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10803-007-0481-2","volume":"38","author":"DS Mandell","year":"2008","unstructured":"Mandell, D. S. (2008). Psychiatric hospitalization among children with autism spectrum disorders. Journal of Autism and Developmental Disorders, 38, 1059\u20131065.","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"2628_CR32","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/CHI.0b013e3181b76658","volume":"48","author":"RN Marcus","year":"2009","unstructured":"Marcus, R. N., Owen, R., Kamen, L., Manos, G., McQuade, R. D., Carson, W. H., & Aman, M. G. (2009). A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 1110\u20131119.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"2628_CR33","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","volume":"347","author":"JT McCracken","year":"2002","unstructured":"McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., et al. (2002). Risperidone in children with autism and serious behavioral problems. New England Journal of Medicine, 347, 314\u2013321.","journal-title":"New England Journal of Medicine"},{"key":"2628_CR34","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1176\/appi.ajp.162.6.1142","volume":"162","author":"CJ McDougle","year":"2005","unstructured":"McDougle, C. J., Scahill, L., Aman, M. G., McCracken, J. T., Tierney, E., Davies, M., et al. (2005). Risperidone for the core symptom domains of autism: Results from the study by the autism network of the research units on pediatric psychopharmacology. American Journal of Psychiatry, 162, 1142\u20131148.","journal-title":"American Journal of Psychiatry"},{"key":"2628_CR35","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1176\/appi.ajp.2011.10060907","volume":"168","author":"HY Meltzer","year":"2011","unstructured":"Meltzer, H. Y., Cucchiaro, J., Silva, R., Ogasa, M., Phillips, D., Xu, J., et al. (2011). Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo- and olanzapine-controlled study. American Journal of Psychiatry, 168, 957\u2013967.","journal-title":"American Journal of Psychiatry"},{"key":"2628_CR36","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1089\/cap.2014.2462","volume":"24","author":"PH Millard","year":"2014","unstructured":"Millard, P. H., McLaren, J. L., & Coffey, D. B. (2014). Lurasidone treatment in a child with autism spectrum disorder with irritability and aggression. Journal Child and Adolescent Psychopharmacology, 24, 354\u2013356.","journal-title":"Journal Child and Adolescent Psychopharmacology"},{"key":"2628_CR37","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/ab.90027","volume":"28","author":"T Moore","year":"2002","unstructured":"Moore, T., Scarpa, A., & Raine, A. (2002). A meta-analysis of serotonin metabolite 5-HIAA and antisocial behavior. Aggressive Behavior, 28, 299\u2013316.","journal-title":"Aggressive Behavior"},{"key":"2628_CR38","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10803-005-5030-2","volume":"35","author":"GH Murphy","year":"2005","unstructured":"Murphy, G. H., Beadle-Brown, J., Wing, L., Gould, J., Shah, A., & Holmes, N. (2005). Chronicity of challenging behaviours in people with severe intellectual disabilities and\/or autism: A total population sample. Journal of Autism and Developmental Disorders, 35, 405\u2013418.","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"2628_CR39","doi-asserted-by":"crossref","first-page":"829","DOI":"10.4088\/JCP.08m04905","volume":"70","author":"M Nakamura","year":"2009","unstructured":"Nakamura, M., Ogasa, M., Guarino, J., Phillips, D., Severs, J., Cucchiaro, J., & Loebel, A. (2009). Lurasidone in the treatment of acute schizophrenia: A double-blind, placebo-controlled trial. Journal of Clinical Psychiatry, 70, 829\u2013836.","journal-title":"Journal of Clinical Psychiatry"},{"key":"2628_CR40","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jpsychires.2013.01.020","volume":"47","author":"HA Nasrallah","year":"2013","unstructured":"Nasrallah, H. A., Silva, R., Phillips, D., Cucchiaro, J., Hsu, J., Xu, J., & Loebel, A. (2013). Lurasidone for the treatment of acutely psychotic patients with schizophrenia: A 6-week, randomized, placebo-controlled study. Journal of Psychiatric Research, 47, 670\u2013677.","journal-title":"Journal of Psychiatric Research"},{"key":"2628_CR41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2788.1988.tb01394.x","volume":"32","author":"JT Newton","year":"1988","unstructured":"Newton, J. T., & Sturmey, P. (1988). The aberrant behaviour checklist: A British replication and extension of its psychometric properties. Journal of intellectual Disability Research, 32, 87\u201392.","journal-title":"Journal of intellectual Disability Research"},{"key":"2628_CR42","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0891-4222(96)00015-7","volume":"17","author":"Y Ono","year":"1996","unstructured":"Ono, Y. (1996). Factor validity and reliability for the Aberrant Behavior Checklist-Community in a Japanese population with mental retardation. Research in Developmental Disabilities, 17, 303\u2013309.","journal-title":"Research in Developmental Disabilities"},{"key":"2628_CR43","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1542\/peds.2008-3782","volume":"124","author":"R Owen","year":"2009","unstructured":"Owen, R., Sikich, L., Marcus, R. N., Corey-Lisle, P., Manos, G., McQuade, R. D., et al. (2009). Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics, 124, 1533\u20131540.","journal-title":"Pediatrics"},{"key":"2628_CR44","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/HRP.0000000000000030","volume":"22","author":"LC Politte","year":"2014","unstructured":"Politte, L. C., Henry, C. A., & McDougle, C. J. (2014). Psychopharmacological interventions in autism spectrum disorder. Harvard Review of Psychiatry, 22, 76\u201392.","journal-title":"Harvard Review of Psychiatry"},{"key":"2628_CR45","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/01.chi.0000220854.79144.e7","volume":"45","author":"L Scahill","year":"2006","unstructured":"Scahill, L., McDougle, C. J., Williams, S. K., Dimitropoulos, A., Aman, M. G., McCracken, J. T., et al. (2006). Research Units on Pediatric Psychopharmacology Autism Network: Children\u2019s Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 1114\u20131123.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"2628_CR46","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.avb.2008.06.003","volume":"13","author":"D Seo","year":"2008","unstructured":"Seo, D., Patrick, C. J., & Kennealy, P. J. (2008). Role of serotonin and dopamine system interactions in the neurobiology of impulsive aggression and its comorbidity with other clinical disorders. Aggression and Violent Behavior, 13, 383\u2013395.","journal-title":"Aggression and Violent Behavior"},{"key":"2628_CR47","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4088\/JCP.09m05305whi","volume":"71","author":"DV Sheehan","year":"2010","unstructured":"Sheehan, D. V., Sheehan, K. H., Shytle, R. D., Janavs, J., Bannon, Y., Rogers, J. E., et al. (2010). Reliability and validity of the mini international neuropsychiatric interview for children and adolescents (MINI-KID). Journal of Clinical Psychiatry, 71, 313\u2013326.","journal-title":"Journal of Clinical Psychiatry"},{"key":"2628_CR48","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1007\/s10803-011-1426-3","volume":"42","author":"M Siegel","year":"2012","unstructured":"Siegel, M., Doyle, K., Chemelski, B., Payne, D., Ellsworth, B., Harmon, J., et al. (2012). Specialized inpatient psychiatry units for children with autism and developmental disorders: A United States survey. Journal of Autism and Developmental Disorders, 42, 1863\u20131869.","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"2628_CR49","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1176\/appi.ajp.2008.07111774","volume":"165","author":"LJ Siever","year":"2008","unstructured":"Siever, L. J. (2008). Neurobiology of aggression and violence. American Journal of Psychiatry, 165, 429\u2013442.","journal-title":"American Journal of Psychiatry"},{"key":"2628_CR50","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/CHI.0b013e318179964f","volume":"47","author":"E Simonoff","year":"2008","unstructured":"Simonoff, E., Pickles, A., Charman, T., Chandler, S., Loucas, T., & Baird, G. (2008). Psychiatric disorders in children with autism spectrum disorders: Prevalence, comorbidity, and associated factors in a population-derived sample. Journal of the American Academy of Child and Adolescent Psychiatry, 47, 921\u2013929.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"2628_CR51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","volume":"212S","author":"GM Simpson","year":"1970","unstructured":"Simpson, G. M., & Angus, J. W. S. (1970). A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica, 212S, 11\u201319.","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"12 suppl","key":"2628_CR52","doi-asserted-by":"crossref","first-page":"32S","DOI":"10.1016\/S0890-8567(99)80003-3","volume":"38","author":"F Volkmar","year":"1999","unstructured":"Volkmar, F., Cook, E. H., Jr, Pomeroy, J., Realmuto, G., & Tanguay, P. (1999). Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues. Journal of the American Academy of Child and Adolescent Psychiatry, 38(12 suppl), 32S\u201354S.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"2628_CR53","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jaac.2013.10.013","volume":"53","author":"F Volkmar","year":"2014","unstructured":"Volkmar, F., Siegel, M., Woodbury-Smith, M., King, B., McCracken, J., & State, M. (2014). American academy of child and adolescent psychiatry (AACAP) committee on quality issues (CQI): Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder. American Academy of Child & Adolescent Psychiatry, 53, 237\u2013257.","journal-title":"American Academy of Child & Adolescent Psychiatry"}],"container-title":["Journal of Autism and Developmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10803-015-2628-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10803-015-2628-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10803-015-2628-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T16:02:58Z","timestamp":1599926578000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10803-015-2628-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,11]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["2628"],"URL":"https:\/\/doi.org\/10.1007\/s10803-015-2628-x","relation":{},"ISSN":["0162-3257","1573-3432"],"issn-type":[{"value":"0162-3257","type":"print"},{"value":"1573-3432","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,11]]}}}